An anti-proliferative drug in the normal breast found previously was the anti-progesterone mifepristone, where a significant down-regulation of Ki-67 protein in the breast was seen in premenopausal women treated for leiomyoma. The gene discussed is MKI67; the disease is leiomyoma.